Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to T-cell Lymphoma
Related studies linked through entity extraction aliases.
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
CD4CAR for CD4+ Leukemia and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)
- Status
- COMPLETED
- Phase
- PHASE1
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients
- Status
- UNKNOWN
- Phase
- N/A
Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE2
p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Doxycycline in Relapsed NHL
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant
- Status
- COMPLETED
- Phase
- N/A
Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE3